Company / Gross Profit
Integra Lifesciences Holdings Gross Profit History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$851.0M
FY2020
5-year range
-
FY2016-FY2020
Trend
-10.7%
vs FY2019
Sector context
#42 of 100
Health Care
What the data says
At $851M, Integra Lifesciences Holdings's gross profit ranks #42 of 100 in the Health Care sector. Declined from $901M to $851M over the past 2 years.
Based on SEC 10-K filings.
$851M in FY2020 with a 3-year CAGR of +9.8%.
Declined from $901M to $851M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +9.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#42 of 100 in Health CareTop 42% of 100This company $851.0M Sector average $1.8B
▼
-53.2% below sector average
Key checks
Key Insights
- 3-year CAGR of +9.8%, indicating consistent growth.
- In FY2020, gross profit decreased 10.7% year-over-year.
- Ranks #42 out of 100 companies in the Health Care sector.
- Peak gross profit was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $851.0M | -10.7% |
| FY2019 | $952.9M | +5.8% |
| FY2018 | $900.9M | +40.1% |
| FY2017 | $643.0M | +15.6% |
| FY2016 | $556.2M | +0.0% |
As of FY2020 · SEC 10-K · Updated Jun 30, 2026